Trials / Conditions / Excessive Sleepiness

Excessive Sleepiness

14 registered clinical trials studyying Excessive Sleepiness — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) NCT06568367	Axsome Therapeutics, Inc.	Phase 3
Completed	Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administr NCT05008341	Axsome Therapeutics, Inc.	Phase 1
Terminated	Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder NCT04788953	Charles A. Czeisler, PhD, MD	Phase 4
Terminated	Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers NCT04618263	Syndeio Biosciences, Inc	Phase 1
Completed	Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT) NCT03881852	Axsome Therapeutics, Inc.	Phase 2
Completed	A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate H NCT03037203	Jazz Pharmaceuticals	Phase 2
Completed	Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in OSA NCT02806895	Jazz Pharmaceuticals	Phase 2
Completed	Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolep NCT02806908	Jazz Pharmaceuticals	Phase 2
Unknown	Palliative Morphine With or Without Concurrent Modafinil NCT01766323	Dr. Rajendra Prasad Government Medical College	Phase 3
Completed	Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disord NCT01080807	Cephalon	Phase 4
Completed	Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Perform NCT00711516	Cephalon	Phase 4
Completed	Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet NCT00758498	Cephalon	Phase 3
Completed	Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chroni NCT00080288	Cephalon	Phase 3
Completed	Provigil (Modafinil) Study by Taiwan Biotech Co. NCT00174174	National Taiwan University Hospital	N/A